Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concerta Augmentation in MDD
NCT00246233Phase 3Completed
- Sponsor
- Janssen Ortho
- Start
- Jun 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Concerta Arm with Placebo Arm (2 arms). Primary endpoint: Change in total Montgomery Asberg Depression Rating Scale score. Started Jun 2005; status: completed.
02
Drugs
methylphenidate-OROS
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00246233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246233.